Enterprise Value
447.9M
Cash
377M
Avg Qtr Burn
-10.38M
Short % of Float
23.12%
Insider Ownership
5.12%
Institutional Own.
89.38%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
MGTA-145 + plerixafor Details Multiple myeloma, Cancer | Phase 2 Update |